- ISIN
- CA89788C1041
- CUSIP
- 89788C104
- Sector
- Healthcare
Highlights
- Market Cap
- $1.84B
- Enterprise Value
- $1.82B
- EPS (TTM)
- -$0.42
- Total Revenue (TTM)
- $1.17B
- Gross Profit (TTM)
- $670.85M
- EBITDA (TTM)
- $276.20M
- Year Range
- $3.25 - $11.83
- Target Price
- $47.21
- ROA (TTM)
- -2.93%
- ROE (TTM)
- -7.09%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
TCNNF Performance Chart
Trulieve Cannabis Corp (TCNNF) is up 7.3% since the beginning of the year. At $9 per share, TCNNF is trading 21.2% below its 52-week high of $12. Investors who bought $1,000 worth of TCNNF shares 5 years ago would now be looking at an investment worth $245.
Loading charts...
Returns By Period
Trulieve Cannabis Corp (TCNNF) has returned 7.25% so far this year and 127.32% over the past 12 months.
Trulieve Cannabis Corp
- 1D
- -1.58%
- 1M
- -2.82%
- YTD
- 7.25%
- 6M
- 54.56%
- 1Y
- 127.32%
- 3Y*
- 34.04%
- 5Y*
- -24.52%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
TCNNF Monthly Returns History
Based on dividend-adjusted daily data since Sep 27, 2018, TCNNF's average daily return is +0.12%, while the average monthly return is +2.58%. At this rate, an investment would double in approximately 2.3 years.
Historically, 43% of months were positive and 57% were negative. The best month was Aug 2025 with a return of +102.3%, while the worst month was Nov 2024 at -47.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.
On a daily basis, TCNNF closed higher 46% of trading days. The best single day was Dec 12, 2025 with a return of +66.6%, while the worst single day was Nov 6, 2024 at -38.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -20.48% | -7.53% | -12.36% | 75.71% | -5.61% | 0.34% | 7.25% | ||||||
| 2025 | -7.59% | -11.27% | -9.18% | 27.98% | -19.03% | -5.00% | 14.47% | 102.30% | -8.41% | -10.05% | -25.66% | 61.22% | 67.65% |
| 2024 | 79.46% | 3.53% | 28.10% | 15.89% | -31.94% | -5.42% | 9.19% | -13.86% | 40.23% | -5.74% | -47.56% | -14.05% | -0.51% |
| 2023 | -10.96% | -4.60% | -13.06% | -3.22% | -21.07% | -8.20% | 8.42% | 33.88% | 7.03% | -26.11% | 23.29% | -6.09% | -31.18% |
| 2022 | -24.26% | 8.93% | -1.91% | -31.52% | 2.58% | -22.16% | 11.29% | 11.67% | -40.58% | 37.06% | 10.64% | -41.27% | -70.90% |
| 2021 | 26.38% | 15.12% | -1.09% | -8.59% | -8.73% | -1.21% | -12.80% | -17.40% | -0.37% | -6.47% | 6.08% | -2.58% | -17.74% |
Benchmark Metrics
Trulieve Cannabis Corp has an annualized alpha of 20.09%, beta of 0.84, and R2 of 0.04 versus S&P 500 Index. Calculated based on daily prices since September 28, 2018.
- This stock participated in 138.23% of S&P 500 Index downside but only 86.73% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.04 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 20.09%
- Beta
- 0.84
- R²
- 0.04
- Upside Capture
- 86.73%
- Downside Capture
- 138.23%
Return for Risk
Risk / Return Rank
TCNNF ranks 76 for risk / return — better than 76% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Trulieve Cannabis Corp (TCNNF) and compare them to S&P 500 Index.
| TCNNF | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.06 | 2.39 | -1.32 |
Sortino ratioReturn per unit of downside risk | 2.42 | 3.25 | -0.83 |
Omega ratioGain probability vs. loss probability | 1.27 | 1.43 | -0.16 |
Calmar ratioReturn relative to maximum drawdown | 2.35 | 3.11 | -0.76 |
Martin ratioReturn relative to average drawdown | 4.69 | 14.38 | -9.69 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Trulieve Cannabis Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Trulieve Cannabis Corp was 93.88%, occurring on Apr 4, 2025. The portfolio has not yet recovered.
The current Trulieve Cannabis Corp drawdown is 82.34%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -93.88%Apr 2025 | 4y 19d | — | 5y 2moMar 2021 - now |
COVID crash2020 | -65.26%Mar 2020 | 1y 5mo | 4mo 19d | 1y 10moOct 2018 - Aug 2020 |
2020 bear market2020 | -32.07%Sep 2020 | 1mo 8d | 1mo 13d | 2mo 21dAug 2020 - Nov 2020 |
2021 correction2021 | -13.53%Mar 2021 | 25d | 7d | 1mo 2dFeb 2021 - Mar 2021 |
2021 correction2021 | -12.78%Jan 2021 | 13d | 9d | 22dJan 2021 - Feb 2021 |
Drawdown Indicators
| TCNNF | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.88% | -56.78% | -37.10% |
Max Drawdown (1Y)Largest decline over 1 year | -54.42% | -9.10% | -45.32% |
Max Drawdown (3Y)Largest decline over 3 years | -77.52% | -18.90% | -58.62% |
Max Drawdown (5Y)Largest decline over 5 years | -91.77% | -25.43% | -66.34% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -82.34% | 0.00% | -82.34% |
Average DrawdownAverage peak-to-trough decline | -61.16% | -10.72% | -50.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.32% | 1.97% | +25.35% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Trulieve Cannabis Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Trulieve Cannabis Corp is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TCNNF relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TCNNF has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TCNNF in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TCNNF has a P/B value of 1.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with TCNNF
Add Trulieve Cannabis Corp to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with TCNNF